Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A machine-learning-derived multi-cell death mode signature predicts melanoma prognosis and reveals an immune-cold tumor microenvironment.

Discover oncology·2026

Same author

A ZDHHC3-USP5-PTRF axis links palmitoylation to ferroptosis-associated phenotypes in melanoma.

Cell death & disease·2026

Same author

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026

Same author

Effects of Moderately Reduced Dietary Net Energy on Growth Performance, Meat Quality and Intestinal Barrier Function in Growing Pigs.

Veterinary sciences·2026

Same author

TYRP1 defines a proliferative melanoma cell subpopulation, driving malignant progression and therapy resistance via the GPNMB-Notch1-SOX10/MITF axis.

Journal of translational medicine·2026

Same author

Bioinformatics and experimental insights into the relationship between ferroptosis and fluoride-induced neurotoxicity.

Neurotoxicology·2026

Search research articles

Related Experiment Video

Updated: Jun 1, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Overexpressed RPS6KA1 and its potential diagnostic value in head and neck squamous cell carcinoma.

Chengjun Hu¹, Jiaheng Xie¹, Xiyun Fei²

¹Department of Plastic and Cosmetic Surgery, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan Province, China.

Discover Oncology

|January 19, 2025

Summary

This summary is machine-generated.

Ribosomal Protein S6 Kinase A1 (RPS6KA1) is upregulated in head and neck squamous cell carcinoma (HNSCC), correlating with immune cell infiltration and potentially serving as a diagnostic and therapeutic biomarker.

Keywords:

Bioinformatics analysis Drug sensitivity analysis Head and neck squamous cell carcinomas Immune environment RPS6KA1

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

Related Experiment Videos

Last Updated: Jun 1, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Development of Compendium for Esophageal Squamous Cell Carcinoma

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

Area of Science:

Oncology
Molecular Biology
Immunology

Background:

Disordered RPS6KA1 expression is linked to various cancers.
The specific role and mechanism of RPS6KA1 in head and neck squamous cell carcinoma (HNSCC) remain unclear.
Understanding RPS6KA1's function in HNSCC is crucial for developing targeted therapies.

Purpose of the Study:

To investigate the role of Ribosomal Protein S6 Kinase A1 (RPS6KA1) in HNSCC.
To explore the association between RPS6KA1 expression and the tumor immune microenvironment.
To identify RPS6KA1 as a potential biomarker for HNSCC diagnosis and treatment.

Main Methods:

Bioinformatics analysis using EBI, GEO, and TCGA databases.
Validation of RPS6KA1 expression via Western blot (WB) and PCR.
Flow cytometry to assess immune cell infiltration and correlation with RPS6KA1.
Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) for pathway analysis.
Drug sensitivity analysis to evaluate therapeutic implications.

Main Results:

RPS6KA1 expression was significantly increased in HNSCC tissues, particularly in advanced stages (III+IV).
RPS6KA1 correlated with various immune cells and factors, including tumor immune score and B cells.
No significant correlation was found between RPS6KA1 and CD4+ or CD8+ T cells.
Drug sensitivity analysis indicated RPS6KA1's predictive value for therapeutic responses.

Conclusions:

RPS6KA1 is overexpressed in HNSCC.
RPS6KA1 may play a role in regulating the HNSCC immune microenvironment.
RPS6KA1 shows potential as a diagnostic and therapeutic biomarker for HNSCC.